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MATHEMATICALLY MODELLING THE DISSOLUTION OF SOLID
DISPERSIONS
MARTIN MEERE∗, SEAN MCGINTY † , AND GIUSEPPE PONTRELLI ‡
Abstract. A solid dispersion is a dosage form in which an active ingredient (a drug) is mixed
with at least one inert solid component. The purpose of the inert component is usually to improve
the bioavailability of the drug. In particular, the inert component is frequently chosen to improve the
dissolution rate of a drug that is poorly soluble in water. The construction of reliable mathematical
models that accurately describe the dissolution of solid dispersions would clearly assist with their
rational design. However, the development of such models is challenging since a dissolving solid
dispersion constitutes a non-ideal mixture, and the selection of appropriate forms for the activity
coefficients that describe the interaction between the drug, the inert matrix, and the dissolution
medium is delicate. In this paper, we present some preliminary ideas for modelling the dissolution
of solid dispersions.
Key words. Solid Dispersion, Mathematical Model, Partial Differential Equations, Activity
Coefficients
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1. Introduction.
1.1. Motivation: poorly soluble drugs. Drugs that are delivered orally via
a tablet should ideally be readily soluble in water. Drugs that are poorly water-
soluble tend to pass through the gastrointestinal tract before they can fully dissolve,
and this typically leads to poor bioavailability of the drug. Unfortunately, many
drugs currently on the market or in development are poorly water-soluble, and this
presents a serious challenge to the pharmaceutical industry. Many strategies have
been developed to improve the solubility of drugs, such as the use of surfactants,
cocrystals, lipid-based formulations, and particle size reduction. The literature on
this topic is extensive, and recent reviews can be found in [1] and [2].
One particularly effective strategy to improve drug solubility is to use a solid
dispersion. A solid dispersion typically consists of a hydrophobic drug embedded in
a hydrophilic polymer matrix, where the matrix can be either in the amorphous or
crystalline state. The drug is preferably in a molecularly dispersed state, but may
also be present in amorphous particles or even in the crystalline form (though this is
usually undesirable); see Figure 1.1.
1.2. Storage, stability and phase separation of solid dispersions. Drug
loading in most dispersions greatly exceeds the equilibrium solubility in the polymer
matrix for typical storage temperatures. Hence these systems are usually unstable,
with phase separation eventually occurring ([7]). In such cases, the drug will
eventually crystallise out or form an amorphous phase separation. However, if the
dispersion is stored well below the glass transition temperature ([3]) for the polymer,
and is kept dry, this can happen extremely slowly. The system is then for all
∗School of Mathematics, National University of Ireland Galway, University Road, Galway, Ireland
(martin.meere@nuigalway.ie).
†Division of Biomedical Engineering, University of Glasgow, Glasgow, G12 8QQ, UK
(sean.mcginty@glasgow.ac.uk).
‡Istituto per le Applicazioni del Calcolo, CNR, Rome, Italy (giuseppe.pontrelli@gmail.com).
341
342 M. MEERE, S. MCGINTY, AND G. PONTRELLI
Molecularly dispersed
drug in the polymer
matrix (desirable)
Drug molecule
Polymer matrix
Crystal drug formation
has occurred (undesirable)
Contains amorphous
drug-rich domains
Fig. 1.1. Adapted from [7]. In this figure, we show three possible structures for a polymer/drug
dispersion. Top: Here the drug is in the molecularly dispersed state, which is usually desirable for
a solid dispersion. Bottom left: Here the dispersion contains drug in the crystalline form. Bottom
right: Here the dispersion contains amorphous drug-rich domains.
practical purposes stable, and is said to be metastable. The humidity of the storage
environment can be an issue because even small amounts of moisture can significantly
affect the glass transition temperature. Hence polymers that have high glass transition
temperatures and that are resistant to water absorption have become popular. An
example of one such polymer is Hydroxypropyl Methylcellulose Acetate Succinate
(HPMCAS).
(successful solid dispersion)(failed solid dispersion)
Fig. 1.2. Adapted from [8]. The drug first dissolves along with the soluble polymer matrix to
generate a supersaturated solution (spring) followed by a decline in the drug concentration in the
media due to either absorption or precipitation (parachute).
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1.3. Drug release from solid dispersions. The spring and parachute concept
is the usual strategy associated with drug release from solid dispersions. When the
dispersion absorbs fluid, the dispersed drug dissolves along with the soluble polymer
to create a solution with a drug concentration that is well above the drug solubility in
the fluid (this is the spring). The dispersion then maintains the drug concentration
at supersaturated levels for a period of hours while it is being absorbed (this is the
parachute); see Figure 1.2.
Unfortunately, despite extensive research, the dissolution behaviour of solid
dispersions is only partially understood. In particular, the precise mechanisms via
which the polymer prolongs the supersaturation of the drug have not been fully
resolved. This makes the design of successful solid dispersions a somewhat hit and
miss affair. Clearly, the construction of reliable mathematical models that capture
the key interactions between drug, polymer and solvent molecules in a dissolving solid
dispersion would greatly assist with their rational design. The ultimate goal of such
modelling is to identify the regions of the parameter space governing the system that
lead to the desired dissolution behaviour for a given pharmaceutical product. Some
previous modelling studies for solid solutions can be found in [9], [10], [11] and [12].
2. Mathematical modelling.
2.1. A multicomponent diffusion model for solid dispersions. We develop
a multicomponent diffusion model for the evolution of the concentrations of the three
components constituting a dissolving solid dispersion. These are the drug molecules
(label 1), the polymer molecules (label 2), and the solvent molecules (label 3). For
simplicity, we shall restrict our attention here to the one-dimensional form of the
equations; that is, the concentrations of the species only depend on a single spatial
variable x.
The chemical potential µi (J/mole) of species i (i = 1, 2, 3) gives the Gibbs free
energy per mole of species i, and is given here by ([4])
µi = µi0 +RT ln(ai)− 2i
∂2Ni
∂x2
(2.1)
where µi0 is the chemical potential of species i in the pure state, R (J/[K·mole]) is
the gas constant, T (K) is the temperature, ai is the activity of species i, and the
term involving 2i > 0 (m
2J/mole) penalises the formation of phase boundaries (see
[5] and [6] for some discussion of this issue). Here Ni is the molar fraction of species
i (i = 1, 2, 3), and the activities can depend on these molar fractions, so that
ai = ai(N1, N2, N3).
The flux of species i (molar·m/s) is given by
Ji = civi(2.2)
where ci (molar), vi (m/s) give the molar concentration and drift velocity, respectively,
of species i. The drift velocity vi gives the average velocity a particle of species i
attains due to the diffusion force acting on it, and is given here by
vi = MiFi = −Mi ∂µi
∂x
(2.3)
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where Mi (mole·s/kg), Fi (J/[m·mole]) give the mobility and diffusion force,
respectively, for species i. Substituting (2.3) in (2.2) and using (2.1) gives
Ji = −Mici ∂µi
∂x
= −Mici
(
RT
ai
∂ai
∂x
− 2i
∂3Ni
∂x3
)
and then using the fact that the activities depend on the molar fractions gives
Ji = −Mici
RT
ai
3∑
j=1
∂ai
∂Nj
∂Nj
∂x
− 2i
∂3Ni
∂x3
 .(2.4)
The molar fraction is related to the molar concentration via
Ni = Vici(2.5)
where Vi (molar
−1) is the molar volume of species i. Using (2.5), we can now write
(2.4) as
Ji = −
3∑
j=1
Dij
∂cj
∂x
+Diε
2
i ci
∂3ci
∂x3
(2.6)
where the Dij (m
2/s) are given by
Dij = Di
Vj
Vi
Ni
ai
∂ai
∂Nj
(i, j = 1, 2, 3)(2.7)
and where
Di = MiRT (Einstein relation)
is the diffusion coefficient for species i. Finally, ε2i = MiVi
2
i /Di > 0 (m
2/molar).
Conservation of mass for species i implies that
∂ci
∂t
+
∂Ji
∂x
= 0
and using (2.6) now gives
∂ci
∂t
=
∂
∂x
 3∑
j=1
Dij(c1, c2, c3)
∂cj
∂x
−Diε2i ci
∂3ci
∂x3
 (i = 1, 2, 3)(2.8)
where we have included the concentration dependence of the diffusion coefficients
Dij here to emphasise that this system is in general a coupled system of nonlinear
diffusion equations. It should be noted that the equations (2.8) are not independent
since V1c1 + V2c2 + V3c3 = 1, and so it is sufficient to solve for two concentrationns
only.
2.2. Activity coefficients. The activities ai are usually written as
ai = γiNi
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where the γi = γi(N1, N2, N3) are referred to as activity coefficients. Equations (2.7)
now give
Dij = Di
Vj
Vi
(
δij +
Ni
γi
∂γi
∂Nj
)
(i, j = 1, 2, 3)(2.9)
where δij is the Kronecker delta. Notice that if γi ≡ constant, then the (2.9) reduce
to Dij = Di and the governing equations decouple to give
∂ci
∂t
= Di
∂
∂x
(
∂ci
∂x
− ε2i ci
∂3ci
∂x3
)
. (i = 1, 2, 3)
If we further have εi = 0, the governing equations reduce to a set of classical linear
diffusion equations.
The details of the interactions between the species in solution are captured
in the modelling by choosing appropriate forms for the activity coefficients γi =
γi(N1, N2, N3). The construction of appropriate forms for the γi for various solutions
is a large subject with a large literature; see, for example, the books [13] and [14].
2.3. Activity coefficients for polymer solutions.
2.3.1. Flory-Huggins Model. The Flory-Huggins model is a lattice-based
model commonly used to describe the thermodynamics of polymer solutions. For a
binary solution in which the subscripts 1 and 2 refer to drug and polymer molecules,
respectively, this model has ([13])
ln(γ1) = ln
(
Φ1
N1
)
+ 1− Φ1
N1
+ χ12Φ
2
2
where
Φ1 =
V1N1
V1N1 + V2N2
, Φ2 =
V2N2
V1N1 + V2N2
.
Here χ12 is the Flory-Huggins interaction parameter that quantifies the balance
between polymer-polymer and polymer-solvent interactions. Note that we need only
specify γ1 here since N2 = 1−N1.
For a ternary solution, consisting of drug molecules, polymer molecules, and
solvent molecules (molar fraction N3, molar volume V3), we have ([13])
ln(γi) = ln
(
Φi
Ni
)
+ 1− Φi
Ni
+ 2Vi
3∑
j=1
Φibij − Vi
3∑
j,k=1
ΦjΦkbjk
where
Φi =
ViNi∑3
j=1 VjNj
for i = 1, 2, 3,
and where the interaction parameters bij (molar) are such that bii = 0 and bij = bji.
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The reference fluid
consists of a collection
of hard spheres
Dispersion forces are
added
Chains are formed
via covalent bonding
Association sites are
included that permit hydrogen
bonding-like interactions
Fig. 2.1. Adapted from [16]. In the SAFT framework, the reference fluid consists of a collection
of hard spheres to which dispersion forces are added. These spheres can form chains via covalent
bonding. Association sites are added to the chains that allow for the inclusion of hydrogen bonding
type interactions.
2.3.2. Statistical Associating Fluid Theory. Statistical Associating Fluid
Theory (SAFT) is a sophisticated tool for developing realistic thermodynamic models
for polymer solutions ([15, 16]). The theory allows for the development of tailored
models for specific polymer/drug systems constituting solid dispersions. For a single
component fluid system, the physical basis of the SAFT approach is illustrated in
Figure 2.1. The reference fluid consists of a system of hard spheres to which weak
dispersion forces are added. These spheres can form chains of a given length via
covalent bonding. Finally, association sites are added to the chains to allow for
hydrogen bonding-type interactions.
The Helmholtz free energy A (J) of the fluid in SAFT is then calculated as follows
A = Aideal +Ahs +Adisp +Achain +Aassoc
where
Aideal = contribution from the ideal fluid,
Ahs = contribution from the hard sphere assumption,
Adisp = contribution from the dispersion force interactions,
Achain = contribution from the covalent bonding,
Aassoc = contribution from the association interactions.
Expressions for each of these quantities have been calculated by the applied statistical
thermodynamics community, and can be found in [16]. A full listing and explanation
of these equations would occupy a number pages, and so for brevity we have omitted
these details here. Once the free energies for the individual components have been
calculated, the free energy for the mixture can then be calculated using mixing rules.
With the free energy of the mixture in hand, the activity coefficients can be
calculated as follows ([12, 13, 14]). We first define the residual Helmholtz free energy
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via
Ares = A−Aideal = Ahs +Adisp +Achain +Aassoc,
and the residual chemical potentials are then given by
µresi = Ares +RT (Z − 1) +
∂Ares
∂Ni
−
3∑
j=1
Nj
∂Ares
∂Nj
,
for i = 1, 2, 3 as before, and where
Z = 1 + ρ∂(A
res/RT )
∂ρ
is the incompressibility factor, with ρ the density of the system. The fugacity of
component i in the mixture is then given by
ϕi =
1
Z exp
(
−µ
res
i
RT
)
.
Finally, the activity coefficient for component i is now given by
γi =
ϕi
ϕi0
,
where ϕi0 is the fugacity of the pure component i.
3. Future work. The following briefly summarises our future research plan for
investigating the behaviour of solid dispersions.
• We shall begin by considering Flory-Huggins type models for polymer
solutions. It is envisaged that the consideration of these simpler systems
will yield mechanistic insights. Once this work has been completed, we
shall use the SAFT framework to develop more realistic models for specific
polymer/drug systems.
• We shall address two main problems. The first of these is the storage
stability problem. For this problem, we shall develop a representative initial
boundary value problem to describe the behaviour of the solid dispersion in
storage. Initially, we shall consider a two component model (polymer/drug)
and identify those parameter regimes that lead to stable, metastable, and
unstable behaviour. It is also worth noting that because we shall be
considering the full non-equilibrium problem, we should also be able to obtain
information concerning the timescales over which phase separation and drug
crystallization occurs. By introducing a third component for water molecules,
the effect of air humidity on storage stability will also be investigated.
• The second problem we shall consider is the dissolution problem. In this case,
we shall develop a representative initial boundary value problem to describe
the dissolution of a solid dispersion. Particular attention will be paid to
identifying the underlying mechanisms and parameter regimes that lead to
the spring and parachute effect.
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